Related Experiment Videos
Interleukin-8 and alcoholic liver disease
1Department of Medicine, Veterans General Hospital-Taipei, Taiwan, ROC.
Zhonghua Yi Xue Za Zhi = Chinese Medical Journal; Free China Ed
|July 27, 1999
Summary
Interleukin-8 (IL-8) is elevated in alcoholic liver disease (ALD), particularly alcoholic hepatitis, and predicts mortality. Lowering IL-8 may offer a therapeutic approach for ALD.
Area of Science:
- Hepatology
- Immunology
- Gastroenterology
Background:
- Alcoholic liver disease (ALD) is characterized by neutrophil infiltration.
- Interleukin-8 (IL-8) is a cytokine that activates neutrophils.
Purpose of the Study:
- To investigate the role of IL-8 in ALD pathogenesis.
- To assess IL-8 as a biomarker for ALD severity and prognosis.
Main Methods:
- Serum and liver tissue IL-8 levels were measured in patients with various stages of ALD and controls.
- Correlation analysis was performed between IL-8 levels, disease severity, neutrophil infiltration, and patient outcomes.
Main Results:
- Serum IL-8 levels were significantly elevated in alcoholic hepatitis compared to other liver conditions and correlated with disease severity and mortality.
- Liver IL-8 levels correlated with neutrophil infiltration in ALD.
- IL-8 levels decreased with alcohol abstinence.
Conclusions:
- Elevated IL-8 is a key factor in ALD pathogenesis, driving neutrophil infiltration.
- Serum IL-8 serves as a valuable biomarker for ALD severity and a predictor of survival in alcoholic hepatitis.
- Targeting IL-8 may represent a promising therapeutic strategy for ALD.